Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Gilberto Lopes, Chief of Medical Oncology at the Sylvester Comprehensive Cancer Center, to discuss the highlights from the World Conference on Lung Cancer 2024.

Join us as we dive into four key studies that could reshape our understanding and approach to lung cancer treatment:

1. Checkmate 816 vs. Checkmate 77T: An exploratory analysis of neoadjuvant chemoimmunotherapy and the ongoing debate about the benefits of post-operative immunotherapy.

2. SKIPPirr Study: Discover how prophylactic strategies can reduce infusion-related reactions with amivantamab.

3. HARMONi-2: A look at a novel PD-1 and VEGF inhibitor compared to Pembrolizumab in metastatic non-small cell lung cancer.

4. TROPION-Lung01: Insights into the performance of the antibody-drug conjugate Dato-DXd against docetaxel, particularly in non-squamous histology.

Tune in for an informative discussion that highlights the latest advancements in lung cancer research and treatment strategies.

Don't forget to like, subscribe, and check out our other episodes for more insights into the current standard of care in oncology!

#OncologyBrothers #LungCancer #WCLC2024 #CancerResearch #MedicalOncology

Website: http://www.oncbrothers.com/

Twitter: https://twitter.com/oncbrothers

Contact us at [email protected]